Core Insights - IDEXX Laboratories, Inc. is a leading company in the animal diagnostics industry, focusing on veterinary diagnostics and software to meet the increasing demand for pet healthcare [1] Group 1: Price Target and Stock Performance - BTIG has set a price target of $800 for IDXX, indicating a potential increase of approximately 25.08% from the current stock price of $639.60 [2] - The stock has experienced a recent decrease of $30.86, or -4.60%, but maintains a strong performance with a 52-week high of $769.98 and a low of $356.14 [2] Group 2: Revenue and Profit Projections - IDEXX's revenue and profit projections for 2026 are expected to exceed Wall Street estimates, driven by robust demand for pet diagnostics [3] - The anticipated growth in veterinary services and increased testing per visit is expected to counterbalance any shifts in clinic visit trends [3] Group 3: Market Capitalization and Trading Activity - The company's market capitalization stands at approximately $51.07 billion, highlighting its significant industry presence [4] - IDXX has a trading volume of 1,016,178 shares, indicating strong investor interest, with a daily trading range between $622.71 and $658.75 [4]